Adaptive Biotechnologies Acquires Sequenta, Could Disrupt Disease Detection
Adaptive Biotechnologies Corporation is buying Sequenta Inc. for an undisclosed sum to create a new company that uses powerful immunosequencing techniques to diagnose and fight cancer, infectious diseases, and autoimmune disorders.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news
More News: Autoimmune Disease | Biotechnology | Cancer | Cancer & Oncology | Infectious Diseases | Medical Devices